63 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

Page of 2 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ADORA1Adenosine A1 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
ADORA3Adenosine A3 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRA1AAdrenoceptor alpha 1AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRA1DAdrenoceptor alpha 1DFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhanced
ADRA2CAdrenoceptor alpha 2CFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRB1Adrenoceptor beta 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRB2Adrenoceptor beta 2, surfaceFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Mixed
AGTR1Angiotensin II receptor, type 1Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
AVPR1BArginine vasopressin receptor 1BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Not detected
AVPR2Arginine vasopressin receptor 2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Mixed
BDKRB2Bradykinin receptor B2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
CALCRCalcitonin receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
CASRCalcium-sensing receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CCKARCholecystokinin A receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CCKBRCholecystokinin B receptorCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CHRM1Cholinergic receptor, muscarinic 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CHRM2Cholinergic receptor, muscarinic 2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CHRM3Cholinergic receptor, muscarinic 3Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CHRM4Cholinergic receptor, muscarinic 4FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CHRM5Cholinergic receptor, muscarinic 5FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CNR1Cannabinoid receptor 1 (brain)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
CNR2Cannabinoid receptor 2 (macrophage)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CYSLTR1Cysteinyl leukotriene receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Mixed
CYSLTR2Cysteinyl leukotriene receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
DRD1Dopamine receptor D1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
DRD2Dopamine receptor D2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
DRD5Dopamine receptor D5Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
EDNRAEndothelin receptor type AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
EDNRBEndothelin receptor type BDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
GABBR1Gamma-aminobutyric acid (GABA) B receptor, 1FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
GABBR2Gamma-aminobutyric acid (GABA) B receptor, 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
GLP2RGlucagon-like peptide 2 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
GRM5Glutamate receptor, metabotropic 5FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
HCAR2Hydroxycarboxylic acid receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
HCAR3Hydroxycarboxylic acid receptor 3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
HRH1Histamine receptor H1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
HRH2Histamine receptor H2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
HTR1A5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupledDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
HTR1B5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
HTR1D5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
HTR1F5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
HTR2A5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR2B5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
HTR2C5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR45-hydroxytryptamine (serotonin) receptor 4, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
HTR75-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
RAS pathway related proteins
Tissue enhanced
LHCGRLuteinizing hormone/choriogonadotropin receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
OPRD1Opioid receptor, delta 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Not detected
OPRK1Opioid receptor, kappa 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
OPRM1Opioid receptor, mu 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched

Page of 2 | next »